RCKT•benzinga•
Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty
Summary
Rocket Pharmaceuticals faces trial delays, multiple downgrades, and reduced success expectations following RP-A501 safety concerns.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 28, 2025 by benzinga